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editorial
“translational research” bridges clini-cal and basic research to formulate research studies based on clinical 
observations and to implement the clinical 
applications of basic research. Although basic 
and clinical scientists have long collaborated, 
translational research challenges investigators 
to move beyond the traditional training of both 
laboratory scientists and clinicians. In 2007, 
we—a clinical researcher (Kong) and a basic 
scientist (Segre)—initiated an interdisciplinary 
project to characterize the human skin micro-
biota associated with both common and rare 
skin disorders (Grice et al., 2008, 2009). We 
set out to better understand the cutaneous 
microbial landscape in healthy individuals and 
patients with atopic dermatitis through the use 
of genomic techniques. The project demanded 
an understanding of a combination of high-
throughput sequencing technology and logis-
tics of clinical research, with knowledge of 
the subtleties of dermatologic disorders. The 
requirements of rigorous translational research 
moved us both beyond the boundaries of our 
individual disciplines.
The paradigm for a translational investigator 
has been the MD–PhD scientist with training in 
both patient care and laboratory research. This 
model results in over 300 MD–PhD graduates 
per year in the United States, 5.9% of whom 
enter residencies in dermatology. Of the recent 
MD–PhD scientists who completed dermatology 
residencies, 56% (39 of 70) remain in academia 
and provide a rich source of researchers in the 
field of dermatology (Brass et al., 2010). In the 
current state of research, there is an increasing 
need to build bridges between clinical and basic 
researchers to translate findings from bench to 
bedside and back again. Are we adequately pre-
paring clinical researchers and basic scientists 
to bridge the translational research gap? If not, 
what skills do we need to learn and teach?
Seven years ago, former National Institutes of 
Health (NIH) director Elias Zerhouni highlight-
ed the complexities and roadblocks inherent to 
modern translational research. He implemented 
the NIH Roadmap with the goal of bringing indi-
viduals from critical disparate disciplines into 
translational research teams (Zerhouni, 2003). 
His model foreshadowed our path toward collab-
oration. We participated in the NIH Roadmap’s 
Human Microbiome Project with our study of 
patients with atopic dermatitis.
MDs interested in laboratory-based research 
face competing demands imposed by patient-
care responsibilities. PhDs interested in clinical 
research face competing demands for projects 
with shorter turnaround times to publish man-
uscripts and to compete for grants. MD–PhDs 
face both sets of competing demands. In addi-
tion, it is difficult for PhD scientists to identify 
ways to work with clinicians and for physicians 
without a laboratory to find a basic researcher 
to coinvestigate a clinical question.
When we met, one of us (Segre) had train-
ing in genetics and basic cell biology, using 
only animal models and cell culture. The other 
(Kong) had training in dermatology and patient-
oriented research. Although neither of us had 
prior experience with a translational research 
team jointly led by a clinical researcher and a 
basic scientist, our common enthusiasm pro-
pelled us into a high-risk research project that 
proved to be rewarding and fruitful. A critical 
issue was learning how to foster a collaboration 
that promoted translational research.
We discuss here what enabled our collabora-
tion and highlight features specific to our inter-
actions as MD and PhD. Although we believe 
that much of our experience is relevant to all 
collaborations, certain features were specific to 
the changing landscape of translational research 
and the inherent differences in our training.
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Maintain strong, open communication
Open, transparent communication is vital, including frank 
discussions about manuscript authorship, abstract and journal 
submissions, potential disagreements, meeting presentations, 
and a mechanism by which to make decisions on bringing 
in additional collaborators. Clearly outline the goals for each 
collaborator in the project, particularly for junior colleagues. 
Define timelines and how the combined efforts of the group 
will allow these goals to be achieved. We intermittently had 
disagreements and encountered misunderstandings, but 
issues were resolved with frank discussion. Each of the points 
delineated below is predicated on effective communication.
team building
A priori, we assumed that one large group meeting with 
all personnel would provide the best opportunity for com-
munication. However, we quickly realized that many team 
members were engaged primarily in either patient care or 
molecular sequence analysis. Although it seems antithetical 
to building one team, we began to hold two separate weekly 
meetings with only the two of us attending both meetings. 
Vital information was lost if only one of us attended either 
meeting, because each of us had a different perspective on 
the many exchanges of information and data. Our clinical 
meetings focused on clinical protocol development, effec-
tive patient recruitment, accurate clinical phenotyping, and 
careful, timely specimen collection and storage. Our labo-
ratory meetings reviewed molecular protocol development, 
technical challenges, sequence data analysis, and statistical 
methodologies. On an as-needed basis, individuals from one 
meeting attended the other to present data or to participate in 
troubleshooting. Quarterly, we held larger meetings involv-
ing all team members to assess progress and set the agenda 
for the next quarter.
How then does each individual on the team comprehend 
the responsibilities of other team members and how each 
person’s role affects the entire project? This requires each 
individual to develop a greater understanding of the role of 
team members with whom they directly interact and then 
use this knowledge to strengthen overall communication and 
operations. For example, after observing the DNA prepara-
tion method, the clinical team saved the laboratory staff frus-
trating hours at the bench by making simple, but important, 
changes to the sample-collection process. Similarly, tailoring 
the data entry and specimen tracking forms to mirror the 
medical-record forms minimized data errors.
In addition to these separate weekly meetings, the two 
of us devoted at least one hour per week to discussing 
milestones and roadblocks. We developed this particu-
lar arrangement over time, after realizing that we needed 
a deeper understanding of each discipline’s strengths and 
major questions. Willingness to learn more about each 
other’s area of expertise fosters an efficient transition 
from bench to bedside and back. Rather than the clinical 
medicine or the laboratory components remaining terra 
incognita to the basic scientist or the clinical researcher, 
respectively, we both work hard to comprehend all parts of 
the project. This approach enables each of us to understand 
more clearly the strengths, challenges, and realities of each 
discipline and of the project as a whole.
Start with a small project
Before embarking on a complicated project with a new col-
laborator, begin with a more manageable project. This lays 
the groundwork for future endeavors by establishing a collab-
orative relationship. We began with a pilot study examining 
the feasibility of skin sampling for microbiome investigation 
(Grice et al., 2008). The pilot study provided vital knowledge, 
not only about how to expand our skin microbiome investi-
gation but also about how each individual functioned as part 
of the research team. Most importantly, the pilot project test-
ed the question “who owns this project?” We crossed a major 
hurdle when the first microbial diversity sequencing data 
were brought to the clinic meeting for analysis. Prior to this, 
there had been unspoken concern that the basic researchers 
would retain isolated control over the intellectually reward-
ing component of the data analysis.
trust and respect each other
This element seems obvious, but trust only develops over 
time and is constantly being challenged. Former colleagues 
and mentors played an important role leading up to the 
initial meetings. For example, Maria Turner became more 
familiar with the work of the Segre lab through two long-
time colleagues, and she also supervised and mentored 
Kong’s fellowship. Turner brought us together to pursue what 
she visualized as a new way to investigate skin microbiota. 
We shared several other colleagues, and hearing from reli-
able colleagues that a potential coinvestigator is trustworthy 
carries significant weight. This emphasizes the importance 
of having a wide range of colleagues and keeping them 
informed about long-term goals. The field of dermatologic 
research is broad and highly interconnected, and it includes 
many whose expertise spans numerous arenas, such as 
immunology, pathology, and intriguing clinical observations.
Negotiate missteps
On one occasion, Segre submitted a meeting abstract for the 
team, thinking that she was saving the others time. However, 
Kong potentially missed an opportunity to write and present 
the abstract at a shared meeting. Don’t be afraid to admit that, 
however good your intentions, your actions were wrong—
and correct your mistake. Obviously, it is important to avoid 
repeating mistakes. When the team was asked to present at 
NIH Clinical Center Grand Rounds, the task was better suited 
for Kong, as the clinician, to communicate the goals and find-
ings of the study. This also brought Kong appropriate recogni-
tion for her role as the lead clinical investigator in the project. 
In turn, Segre presented at the Cold Spring Harbor meeting 
“The Biology of Genomes,” which recognized her role as the 
head of a large-scale sequencing project. Understanding and 
respecting that each person brings a unique strength to the 
project form the foundation of an effective team approach 
to science. As our working relationship matured, we learned 
to build on each other’s strengths and compensate for each 
other’s weaknesses.
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Conclusion
To collaborate effectively requires one to be both a bit self-
ish and a bit selfless. Small individual sacrifices can achieve 
a higher satisfaction quotient for everyone. Conversely, 
stating what you need for professional recognition is an 
important part of participating in a collaborative effort, 
and it does not conflict with the goals of the rest of the 
group. There is often a mechanism in place for producing a 
win–win outcome if the team takes the time to evaluate the 
most important criteria for each individual’s personal and 
professional success. Examples may include providing rea-
sonable technical expertise and assistance to further a team 
member’s research, which may be outside the scope of the 
main project, or alternating first authorship on submitted 
manuscripts.
Although the above approach to research may not apply 
well in all settings, we have established that an MD and a 
PhD can collaborate to perform translational investiga-
tion. We have moved from operating in separate spheres to 
building a coordinated research team that shares clinical 
samples, research trainees, and, most importantly, ideas. 
Each individual’s involvement in this project was more than 
a preplanned career transition; it was a chance to achieve 
a personal goal. Although we have not addressed in this 
Editorial the process of securing institutional commitment 
and support, this is also a crucial element for the success of 
translational research projects.
The complexity of modern biomedical research continues 
to increase. What types of novel state-of-the-art techno logies 
can be used in patient-oriented research? How can we fos-
ter relationships among researchers with different areas of 
expertise? Science has traditionally recognized single indi-
viduals as principal investigators of projects. By contrast, 
complex transdisciplinary projects often demand team 
approaches. Thus, team science creates challenges for tra-
ditional institutional mechanisms for recognizing scientific 
achievement. This issue is now being addressed with respect 
to funding mechanisms, authors’-contribution statements 
for publications, institutional promotion/tenure committees, 
and national and international organizations, such as the 
Society for Investigative Dermatology.
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